速避凝治疗不稳定型冠状动脉疾病的临床观察  

Clinical Observation on Low Molecular Weight HeparinUsed to Treat Unstable Coronary Artery Disease

作　　者：谭湘明[1] 侯爱琼 

机构地区：[1]郴州医专心脑血管疾病研究所,湖南郴州423000 [2]宜章县中医职业中专附属医院,湖南宜章424200

出　　处：《郴州医学高等专科学校学报》2001年第3期156-158,共3页

摘　　要：目的　观察速避凝治疗不稳定型冠状动脉疾病 (VCAD)的临床疗效及安全性。方法　对照组采用常规治疗 ,治疗组采用常规治疗加速速凝治疗 ,疗程 30天。结果　治疗组总有效率 (93.33% )明显高于对照组 (73.0 7% ) (p <0 .0 5 ) ,而且治疗前后血液流变学变化也具显著差异 (p <0 .0 5 ,<0 .0 1)。结论　在常规治疗基础上加用速避凝 ,能有效地控制心绞痛发作 ,减少心性事件发生率 。Objective To observe the treatment outcome and safety of low molecular weight heparin (LMWH) used to treat unstable coronary artery disease (UCAD).Methods Control group and case group were treated with commonpractice and with the addition of LMWH respectively, the treatment course was 30 days.Results The total effective rate of the LMWH group (93.33%) was significantly higher than that of the control group (73.07%) (p<0.05), and there were significant differences in the changes of the blood reheology between before treatment and after treatment (p<0.05,<0.01).Conclusion The fit of angina pectoris can be controlled efficiently and the incidence tate of cardiogenic death can be reduced through the treatment with LMWH.

关 键 词：速避凝治疗 冠状动脉疾病 不稳定型心肌梗死 

分 类 号：R542.22[医药卫生—心血管疾病] R543.3[医药卫生—内科学]